Steve Yang

CRDMO executive, major pharma R&D leader & biotech entrepreneur, Co-CEO at #WuXiAppTec, previously worked at #AstraZeneca, #Pfizer and a biotech start-up

[WuXi AppTec @WuXi_AppTec]

As an integrated #testing platform across the full life cycle of discovery and development, WuXi Testing, one of the key business segments of WuXi AppTec, provides "end-to-end" testing services for novel drug developers and medical device manufacturers. With our wide-ranging expertise, we help our customers at every developmental stage, advancing their endeavors to bring life-saving products to patients in need.

Ready to see innovation in action? Watch the video for an exclusive one-minute glimpse into our meaningful work!

#DMPK #Bioanalytical #SafetyAssessment #ClinicalTrials #Innovation

[Longwood Fund @LongwoodFund]

A fun plenary on the state of innovation moderated by @drcwestphal at @WuXi_AppTec Global Forum with @mmammen @JMaraganore @dramyabernethy @DonIngber Søren Møller.

[WuXi AppTec @WuXi_AppTec]

Thank you to the thousands of friends and colleagues who joined us on Tuesday for our annual #WuXiGlobalForum at #JPM24. We’re immensely grateful to our distinguished panelists who shared their remarkable insights and expertise.

As a convener within the global healthcare community, we are truly inspired by the collaboration, innovative thinking, and wisdom shared.

#TakingBOLDAction will lead to real change for patients and families around the world.

[Karen Knudsen, MBA PhD @DrKarenKnudsen]

I was honored to join @Joseph_C_Wu and @DrBobGabbay at the #WuXiGlobalForum for an important discussion on breakthrough innovation and patient-focused collaboration. Thank you to @MontaiHealth co-founder and CEO Margo Georgiadis for moderating!

[WuXi AppTec @WuXi_AppTec]

🌟The 12th annual WuXi Global Forum is TODAY! 🌟

For those who are registered, we are excited to see you in San Francisco! Please get ready for insightful discussions, which start at 1:30 pm PST.

Learn more about today’s program and speakers here: https://t.co/aHR8cTJsy1

#WuXiGlobalForum #JPM24 #JPM2024

[WuXi AppTec @WuXi_AppTec]

We are delighted to announce the commissioning of two new #peptide #manufacturing plants, one at our Changzhou facility and another at the new Taixing site in China. This significant #expansion has increased our Solid-Phase Peptide Synthesis (SPPS) total reactor volume to 32,000 liters, addressing the surging global demand for peptide therapeutics.

At WuXi AppTec, we will continue to focus on enhancing our #CRDMO platform capability and capacity, accelerating innovative therapies to patients globally.

https://t.co/zVykcCyW9q

[WuXi AppTec @WuXi_AppTec]

#WuXiGlobalForum 2024 is just around the corner! 🎉

We are honored that 30+ distinguished experts will be speaking at our 12th annual marquee event to thousands of industry representatives from around the world.

Panels include:
1. State of Innovation 2024
2. Breaking Barriers. Leaping Forward.
3. Opening Up New Horizons: Spotlight on Cancer
4. Leading Transformation: The Next Wave Therapeutics
5. Delivering on Future Platform Solutions
6. Scaling Breakthroughs Forward

Join us on January 9th as we come together to address some of the biggest challenges in our industry and work towards actionable solutions for patients around the world.

Learn more about our program and speakers: https://t.co/aHR8cTJsy1

#JPM24 #JPM2024 #JPMWeek

[WuXi AppTec @WuXi_AppTec]

High throughput, unwavering precision, and consistent efficiency are three important factors in preclinical research. Take a closer look at how our Laboratory Testing Division continuously expands the platform and upgrades the #automation level of workstations to improve work #efficiency and the #quality of research data. We are proud to help customers expedite the drug development process, delivering ground-breaking therapies to patients faster.

Looking to the future, WuXi AppTec remains committed to embracing new capabilities and cutting-edge technologies, constantly pushing the boundaries of innovation.

👉 https://t.co/BO6VtI4t9S

#Lifescience #Innovation

[WuXi AppTec @WuXi_AppTec]

Explore the comprehensive capabilities of WuXi Testing!

As a vital business segment of WuXi AppTec, WuXi Testing provides "end-to-end" testing services for novel drug developers and medical device manufacturers. Leveraging diverse expertise at every stage of development, we offer customers insights from extensive research data analytics needed for the R&D process and advance their endeavors to bring life-saving products to patients in need.

Enjoy the read, and stay tuned for more exciting progress updates! https://t.co/RVrpa7tv7I

#DMPK #Bioanalytical #SafetyAssessment #ClinicalTrials #Innovation

[WuXi AppTec @WuXi_AppTec]

Now in its 12th year, the WuXi Global Forum will take place on January 9th, 2024 in #SanFrancisco during the 2024 J.P. Morgan Healthcare Conference. Global leaders and innovators will once again convene to catalyze new thinking on this global stage as we strive to advance breakthroughs faster for patients.

🎟️ #WuXiGlobalForum 2024 is complimentary and by invitation only. If you would like to participate in the conversations, please visit https://t.co/aHR8cTJsy1 to request a ticket.

#TakingBOLDAction #JPM24 #JPM2024 #JPMWeek #Healthcare #Biotechnology #Innovation

[WuXi AppTec @WuXi_AppTec]

Proud moment! We are honored to receive the 2023 Global Contract Research, Development, and Manufacturing Organization Company of the Year Award from @FrostBPAwards. This recognition is a testament to the great support we provided for global customers through the unique CRDMO and CTDMO models. By leveraging integrated, end-to-end platforms, we enable customers’ life-saving work, bring positive impacts to the #healthcare industry, and advance discoveries and groundbreaking treatments to patients.

https://t.co/UjS31LlOkd

#innovation #drugdiscovery #FrostAwards

[WuXi Discovery Services @WuXi_Discovery]

With state-of-the-art technologies and laboratory equipment, #CRELUX enables global customers with innovative solutions to perform their work faster, more efficiently and more successfully.

#Munich #DrugDiscovery #Biotechnology #Biophysics #DrugDevelopment

[WuXi AppTec @WuXi_AppTec]

WuXi AppTec, through its @WuXi_Discovery business, is unveiling DELvision, a powerful #DEL-based toolset for AIphafold-assisted drug discovery and target sciences. We continuously strive to provide innovative and cutting-edge technologies to our partners in order to drive R&D efficiencies.

📌 https://t.co/vzObaO6oB9

#drugdevelopment #drugdiscovery #biology

[WuXi Discovery Services @WuXi_Discovery]

WuXi AppTec contributed to a research article in Cell Chemical Biology demonstrating the conversion of ligands identified from DNA-encoded library (DEL) screening into highly functional, cell-active, bioluminescence resonance energy transfer (BRET) probes. https://t.co/EbgmmrpEEB

[WuXi AppTec @WuXi_AppTec]

Tune in TODAY at 8am or 8pm PDT to see prominent industry experts discuss our industry's progress and the path toward catalyzing change for patients.

Don't miss out! 👉 https://t.co/b4U6lOHwKG

#TakingBOLDAction #Biotechnology #PatientsFirst #DrugDiscovery #Oncology #RareDisease #CNS

[Michael Ringel, JD PhD @M_S_Ringel]

New modalities will be a key driver of growth for the #biopharma industry. Which are progressing most rapidly with the biggest potential impact for patients?: https://t.co/MaCY5A5QjB

[WuXi AppTec @WuXi_AppTec]

Revolutionary advancements in neuroscience are reshaping treatment methods for brain & central nervous system disorders. Our "Overcoming CNS Challenges" conversation with Rudolph Tanzi & Steve Yang, explores the obstacles hindering the progress of effective CNS treatments.

[WuXi AppTec @WuXi_AppTec]

Mark your calendars and join us for the riveting BOLD Ep. III online event coming up on July 27!

🎟️ Reserve your complimentary ticket to watch our broadcast, airing twice at 8-10 am and 8-10 pm PDT: https://t.co/OicFZN2FkC

#TakingBOLDAction #Neurology #ClinicalResearch

[WuXi AppTec @WuXi_AppTec]

For over four decades, the elusive #KRAS oncoproteins remained 'undruggable', with few effective inhibitors making their way to the clinic. Six months ago, @Mirati's Krazati (adagrasib) earned accelerated approval for treating adult patients with KRAS G12C-mutated advanced or metastatic non-small cell lung cancer.

WuXi AppTec recently had an insightful conversation with Matthew Marx, Senior Vice President, Drug Discovery at Mirati Therapeutics, to reflect on the journey of discovering and developing adagrasib. Read the full story here: https://t.co/ycxT1mOv9b

#DrugDiscovery #PrecisionMedicine #Biotechnology #CancerResearch

[WuXi AppTec @WuXi_AppTec]

Thank you to our valued customers, partners, and friends for joining us at the WuXi Innovation Day Reception in Boston during #BIO2023! The evening was full of excitement as we gathered to exchange perspectives and discuss the future of biotechnology and healthcare innovation. We truly appreciate our incredible local leaders and guest speakers who joined us - @drcwestphal from @LongwoodFund, @mpreminger from @JNJInnovation, and Leonide Saad from @alkeuspharma – for inspiring us with their important work in advancing breakthroughs for patients.

Our heartfelt gratitude also goes to all attendees for their contributions, passion, and shared vision in advancing innovation that matters. THANK YOU @IAmBiotech for convening us together and for driving innovation forward.

Let's harness this momentum to further push boundaries, ignite collaborations, and shape the future of health together.

#WuXiAppTec #BIO23 #Biotechnology #Innovation #Collaboration #WuXiInnovations #WuXiInnovationDay